Clinical Trial Update: CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing CF101 to methotrexate for active rheumatoid arthritis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CF101 (piclidenoson)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Can-Fite BioPharma | Conditions: Rheumatoid Arthritis | Phase 3 | Status: TERMINATED